Literature DB >> 11753102

IPEX is a unique X-linked syndrome characterized by immune dysfunction, polyendocrinopathy, enteropathy, and a variety of autoimmune phenomena.

C L Bennett1, H D Ochs.   

Abstract

The rare syndrome known as IPEX (OMIM: 304930) is characterized by immune-dysfunction, polyendocrinopathy, enteropathy, and X-linked inheritance. The gene responsible for IPEX maps to Xp11.23-q13.3, a region of the X chromosome that also harbors the Wiskott-Aldrich syndrome gene ( WASP ). IPEX syndrome results from mutations of a unique DNA binding protein gene, FOXP3. Mutations invariably impair the seemingly essential forkhead domain of the protein, which is uniquely located in the carboxyl terminus, affecting protein function. In this review, we describe the identification of IPEX as a unique X-linked syndrome, the clinical features of IPEX, mutations of the immune-specific FOXP3 DNA binding protein, and bone marrow transplantation as a potential cure for the syndrome, which is usually lethal within the first year of life in affected males.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11753102     DOI: 10.1097/00008480-200112000-00007

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  59 in total

Review 1.  New frontiers in primary immunodeficiency disorders: immunology and beyond….

Authors:  Eleonora Gambineri
Journal:  Cell Mol Life Sci       Date:  2011-10-19       Impact factor: 9.261

2.  Kidney injuries related to ipilimumab.

Authors:  Hassane Izzedine; Victor Gueutin; Chems Gharbi; Christine Mateus; Caroline Robert; Emilie Routier; Marina Thomas; Alain Baumelou; Philippe Rouvier
Journal:  Invest New Drugs       Date:  2014-04-01       Impact factor: 3.850

Review 3.  Epithelia: lymphocyte interactions in the gut.

Authors:  Stephanie Dahan; Franziska Roth-Walter; Paul Arnaboldi; Shradha Agarwal; Lloyd Mayer
Journal:  Immunol Rev       Date:  2007-02       Impact factor: 12.988

4.  Naturally occurring and inducible T-regulatory cells modulating immune response in allergic asthma.

Authors:  Halvor S McGee; Devendra K Agrawal
Journal:  Am J Respir Crit Care Med       Date:  2009-05-15       Impact factor: 21.405

5.  Retinoic acid primes human dendritic cells to induce gut-homing, IL-10-producing regulatory T cells.

Authors:  G Bakdash; L T C Vogelpoel; T M M van Capel; M L Kapsenberg; E C de Jong
Journal:  Mucosal Immunol       Date:  2014-07-16       Impact factor: 7.313

6.  Solution structure and backbone dynamics of the DNA-binding domain of FOXP1: insight into its domain swapping and DNA binding.

Authors:  Yuan-Ping Chu; Chia-Hao Chang; Jia-Hau Shiu; Yao-Tsung Chang; Chiu-Yueh Chen; Woei-Jer Chuang
Journal:  Protein Sci       Date:  2011-04-11       Impact factor: 6.725

Review 7.  Targeting the "cytokine storm" for therapeutic benefit.

Authors:  Riccardo V D'Elia; Kate Harrison; Petra C Oyston; Roman A Lukaszewski; Graeme C Clark
Journal:  Clin Vaccine Immunol       Date:  2013-01-02

8.  Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome.

Authors:  Gulbu Uzel; Elizabeth P Sampaio; Monica G Lawrence; Amy P Hsu; Mary Hackett; Morna J Dorsey; Richard J Noel; James W Verbsky; Alexandra F Freeman; Erin Janssen; Francisco A Bonilla; Joseph Pechacek; Prabha Chandrasekaran; Sarah K Browne; Anahita Agharahimi; Ahmed M Gharib; Sara C Mannurita; Jae Joon Yim; Eleonora Gambineri; Troy Torgerson; Dat Q Tran; Joshua D Milner; Steven M Holland
Journal:  J Allergy Clin Immunol       Date:  2013-03-25       Impact factor: 10.793

9.  The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation.

Authors:  J A Bluestone; W Liu; J M Yabu; Z G Laszik; A Putnam; M Belingheri; D M Gross; R M Townsend; F Vincenti
Journal:  Am J Transplant       Date:  2008-10       Impact factor: 8.086

10.  B cells are critical for autoimmune pathology in Scurfy mice.

Authors:  Susanne Aschermann; Christian H K Lehmann; Sidonia Mihai; Georg Schett; Diana Dudziak; Falk Nimmerjahn
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.